Body Vision Medical
Body Vision Medical is redefining lung cancer diagnostics and therapies with its AI-driven imaging technology, LungVision®. This system enables real-time, high-precision navigation for biopsies and localized therapies of pulmonary nodules, enhancing accuracy and confidence for clinicians. The technology addresses the challenge of CT-to-body divergence, a common issue in bronchoscopy that affects diagnostic yield. Body Vision's proprietary AI Tomo® technology corrects for this divergence, potentially increasing diagnostic yields to approximately 95%. The LungVision system transforms any 2D C-arm into an advanced 3D imaging system with navigation capabilities, empowering pulmonologists and thoracic surgeons to accurately locate and biopsy small lung lesions. The company aims to make cutting-edge lung cancer interventions more accessible and improve patient outcomes.
Body Vision Medical
Body Vision Medical is redefining lung cancer diagnostics and therapies with its AI-driven imaging technology, LungVision®. This system enables real-time, high-precision navigation for biopsies and localized therapies of pulmonary nodules, enhancing accuracy and confidence for clinicians. The technology addresses the challenge of CT-to-body divergence, a common issue in bronchoscopy that affects diagnostic yield. Body Vision's proprietary AI Tomo® technology corrects for this divergence, potentially increasing diagnostic yields to approximately 95%. The LungVision system transforms any 2D C-arm into an advanced 3D imaging system with navigation capabilities, empowering pulmonologists and thoracic surgeons to accurately locate and biopsy small lung lesions. The company aims to make cutting-edge lung cancer interventions more accessible and improve patient outcomes.